GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kairos Pharma Ltd (AMEX:KAPA) » Definitions » NonCurrent Deferred Income Tax

KAPA (Kairos Pharma) NonCurrent Deferred Income Tax : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Kairos Pharma NonCurrent Deferred Income Tax?

Non-Current Deferred Income Tax represents the non-current portion of deferred income taxes, which is the difference in income recognition between tax laws and the accounting methods.

Kairos Pharma's non-current deferred income tax for the quarter that ended in Dec. 2024 was $0.00 Mil.

Kairos Pharma NonCurrent Deferred Income Tax Historical Data

The historical data trend for Kairos Pharma's NonCurrent Deferred Income Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kairos Pharma NonCurrent Deferred Income Tax Chart

Kairos Pharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
NonCurrent Deferred Income Tax
- - - - -

Kairos Pharma Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
NonCurrent Deferred Income Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kairos Pharma NonCurrent Deferred Income Tax Related Terms

Thank you for viewing the detailed overview of Kairos Pharma's NonCurrent Deferred Income Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Kairos Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kairos Pharma Ltd (AMEX:KAPA) » Definitions » NonCurrent Deferred Income Tax
Comparable Companies
NERV AAGH BRTX BIXT SNSE AFMD BCDA NYMXF SPRB LPTX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
2355 Westwood Boulevard, 139, Los Angeles, CA, USA, 90064
Website
https://kairospharma.com
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.